Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease
- PMID: 12938734
- DOI: 10.1080/1521654031000153058
Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disease with no known cure and affects approximately 1% of the elderly population. The major question in PD relates to the selective loss of dopaminergic neurons in patients. The underlying mechanism of genetic dysfunction and environmental toxins in contributing to the pathogenesis of PD may be oxidative stress. The interactions of genetic and environmental factors in PD may provide some answers to the longstanding question. In particular, the possibility that iron may provide selectivity to genetic susceptibility or dopamine reactivity in dopaminergic neuronal death is enhanced by the neuroprotection demonstrated in transgenic mice overexpressing ferritin or the use of iron chelators in MPTP-induced PD mouse. It will be important to dissect and understand the contributions of genes, environment and intrinsic cellular states in the generation and progression of the pathophysiology of PD.
Similar articles
-
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.Ann N Y Acad Sci. 2005 Dec;1057:296-318. doi: 10.1196/annals.1356.023. Ann N Y Acad Sci. 2005. PMID: 16399902 Review.
-
Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.Pharmacol Ther. 2007 Jun;114(3):327-44. doi: 10.1016/j.pharmthera.2007.04.001. Epub 2007 Apr 19. Pharmacol Ther. 2007. PMID: 17521740 Review.
-
Iron transport in Parkinson's disease.Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S209-11. doi: 10.1016/S1353-8020(09)70816-8. Parkinsonism Relat Disord. 2009. PMID: 20082992
-
Pathogenesis and animal studies of Parkinson's disease.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):323-32. Curr Opin Neurol Neurosurg. 1993. PMID: 8507901 Review.
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
Cited by
-
Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease.J Biol Chem. 2011 Sep 23;286(38):33380-9. doi: 10.1074/jbc.M111.268409. Epub 2011 Jul 27. J Biol Chem. 2011. PMID: 21795716 Free PMC article.
-
Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.Parkinsons Dis. 2011;2011:393769. doi: 10.4061/2011/393769. Epub 2011 Apr 13. Parkinsons Dis. 2011. PMID: 21603178 Free PMC article.
-
Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.Neuroscience. 2007 Mar 16;145(2):654-68. doi: 10.1016/j.neuroscience.2006.12.030. Epub 2007 Jan 29. Neuroscience. 2007. PMID: 17258864 Free PMC article.
-
Cellular senescence in honey bee brain is largely independent of chronological age.Exp Gerontol. 2006 Nov;41(11):1117-25. doi: 10.1016/j.exger.2006.08.004. Epub 2006 Oct 18. Exp Gerontol. 2006. PMID: 17052880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical